9308 Federal Register / Vol. 86, No. 28 / Friday, February 12, 2021 / Proposed Rules 

substantial changes to the amendment. 

IPCB also adopted minor administrative 

changes such as alphabetizing 

compound names and adopting IUPAC 

names for some compounds listed at 35 

IAC 211.7150. 

III. EPA’s Analysis of the Proposed SIP 

Revision 

In 2014, EPA received a petition 

requesting that cis-1,1,1,4,4,4- 

hexafluorobut-2-ene be exempted from 

VOC control based on its low reactivity, 

using ethane as a benchmark. Based on 

the mass maximum incremental 

reactivity value for the compound being 

less than that of ethane, EPA concluded 

that this compound makes negligible 

contributions to tropospheric ozone 

formation. Additionally, EPA 

considered risks not related to 

tropospheric ozone associated with 

currently allowed uses of the chemical 

to be acceptable. As a result, on 

November 28, 2018, EPA responded to 

the petition by amending 40 CFR 

51.100(s) to exclude this chemical 

compound from the definition of VOC 

for purposes of preparing SIPs to attain 

the national ambient air quality 

standard for ozone under title I of the 

CAA. See 83 FR 61127 (Nov. 28, 2018). 

EPA’s action became effective on 

January 28, 2019. 

By excluding cis-1,1,1,4,4,4- 

hexafluorobut-2-ene from the definition 

of VOM at 35 IAC 211.7150, Illinois’ 

proposed SIP revision is consistent with 

EPA’s action amending the definition of 

VOC at 40 CFR 51.100(s). 

IV. What action is EPA taking? 

EPA is proposing to approve the 

revision to the Illinois SIP at 35 IAC 

211.7150 submitted on October 20, 

2020. The proposed approval of the 

revision meets the criteria of the CAA 

and applicable Federal regulations. 

V. Incorporation by Reference 

In this rule, EPA is proposing to 

include in a final EPA rule regulatory 

text that includes incorporation by 

reference. In accordance with 

requirements of 1 CFR 51.5, EPA is 

proposing to incorporate by reference 

revisions to 35 IAC 211.7150 ‘‘Volatile 

Organic Material (VOM) or Volatile 

Organic Compound (VOC)’’, effective 

August 18, 2020. EPA has made, and 

will continue to make, these documents 

generally available through 

www.regulations.gov and at the EPA 

Region 5 Office (please contact the 

person identified in the FOR FURTHER

INFORMATION CONTACT section of this 

preamble for more information). 

VI. Statutory and Executive Order 

Reviews 

Under the CAA the Administrator is 

required to approve a SIP submission 

that complies with the provisions of the 

CAA and applicable Federal regulations. 

42 U.S.C. 7410(k); 40 CFR 52.02(a). 

Thus, in reviewing SIP submissions, 

EPA’s role is to approve state choices, 

provided that they meet the criteria of 

the CAA. Accordingly, this action 

merely approves state law as meeting 

Federal requirements and does not 

impose additional requirements beyond 

those imposed by state law. For that 

reason, this action: 

• Is not a significant regulatory action 

subject to review by the Office of 

Management and Budget under 

Executive Orders 12866 (58 FR 51735, 

October 4, 1993) and 13563 (76 FR 3821, 

January 21, 2011); 

• Is not an Executive Order 13771 (82 

FR 9339, February 2, 2017) regulatory 

action because SIP approvals are 

exempted under Executive Order 12866; 

• Does not impose an information 

collection burden under the provisions 

of the Paperwork Reduction Act (44 

U.S.C. 3501 et seq.); 

• Is certified as not having a 

significant economic impact on a 

substantial number of small entities 

under the Regulatory Flexibility Act (5 

U.S.C. 601 et seq.); 

• Does not contain any unfunded 

mandate or significantly or uniquely 

affect small governments, as described 

in the Unfunded Mandates Reform Act 

of 1995 (Pub. L. 104–4); 

• Does not have federalism 

implications as specified in Executive 

Order 13132 (64 FR 43255, August 10, 

1999); 

• Is not an economically significant 

regulatory action based on health or 

safety risks subject to Executive Order 

13045 (62 FR 19885, April 23, 1997); 

• Is not a significant regulatory action 

subject to Executive Order 13211 (66 FR 

28355, May 22, 2001); 

• Is not subject to requirements of 

Section 12(d) of the National 

Technology Transfer and Advancement 

Act of 1995 (15 U.S.C. 272 note) because 

application of those requirements would 

be inconsistent with the Clean Air Act; 

and 

• Does not provide EPA with the 

discretionary authority to address, as 

appropriate, disproportionate human 

health or environmental effects, using 

practicable and legally permissible 

methods, under Executive Order 12898 

(59 FR 7629, February 16, 1994). 

In addition, the SIP is not approved 

to apply on any Indian reservation land 

or in any other area where EPA or an 

Indian tribe has demonstrated that a 

tribe has jurisdiction. In those areas of 

Indian country, the rule does not have 

tribal implications and will not impose 

substantial direct costs on tribal 

governments or preempt tribal law as 

specified by Executive Order 13175 (65 

FR 67249, November 9, 2000). 

List of Subjects in 40 CFR Part 52 

Environmental protection, Air 

pollution control, Incorporation by 

reference, Intergovernmental relations, 

Ozone, Reporting and recordkeeping 

requirements, Volatile organic 

compounds. 

Dated: February 4, 2021. 

Cheryl Newton, 

Acting Regional Administrator, Region 5. 

[FR Doc. 2021–02744 Filed 2–11–21; 8:45 am] 

BILLING CODE 6560–50–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

42 CFR Part 100 

RIN 0906–AB24 

National Vaccine Injury Compensation 

Program: Revisions to the Vaccine 

Injury Table; Notice of Proposed 

Rulemaking; Public Comment Period; 

Delay of Effective Date 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services (HHS). 

ACTION: Notice of proposed rulemaking; 

proposed delay of effective date; request 

for comments. 

SUMMARY: In accordance with the 

Presidential directive as expressed in 

the memorandum of January 20, 2021, 

from the Assistant to the President and 

Chief of Staff, entitled ‘‘Regulatory 

Freeze Pending Review,’’ this action 

proposes, following a brief public 

comment period, to further delay until 

April 23, 2021, the effective date of the 

rule entitled ‘‘National Vaccine Injury 

Compensation Program: Revisions to the 

Vaccine Injury Table,’’ published in the 

Federal Register on January 21, 2021. 

That final rule is scheduled to take 

effect on February 22, 2021. HHS seeks 

comments on this proposed delay, 

which would allow it additional 

opportunity for review and 

consideration of the new rule. 

DATES: Written comments and related 

material to this proposed rule must be 

received to the online docket via https:// 

www.regulations.gov on or before 

February 16, 2021. 

ADDRESSES: You may submit written 

comments electronically by the 

Federal Register / Vol. 86, No. 28 / Friday, February 12, 2021 / Proposed Rules 9309 

following method: Federal eRulemaking 

Portal: http://www.regulations.gov. 

Follow the instructions on the website 

for submitting comments. 

Instructions. Include the HHS Docket 

No. HRSA–2021–0001 in your 

comments. All comments received will 

be posted without change to http://

www.regulations.gov. Please do not 

include any personally identifiable or 

confidential business information you 

do not want publicly disclosed. 

FOR FURTHER INFORMATION CONTACT: 

Please visit the National Vaccine Injury 

Compensation Program’s website, 

https://www.hrsa.gov/vaccine

compensation/, or contact Tamara 

Overby, Acting Director, Division of 

Injury Compensation Programs, 

Healthcare Systems Bureau, HRSA, 

Room 08N146B, 5600 Fishers Lane, 

Rockville, MD 20857; by email at 

vaccinecompensation@hrsa.gov; or by 

telephone at (855) 266–2427. 

SUPPLEMENTARY INFORMATION: HHS 

published a notice of proposed 

rulemaking on July 20, 2020 (85 FR 

43794), and final rule on January 21, 

2021 (86 FR 6249). That final rule 

amended the provisions of 42 CFR 100.3 

by removing Shoulder Injury Related to 

Vaccine Administration, vasovagal 

syncope, and Item XVII from the 

Vaccine Injury Table. The January 20, 

2021, memorandum from the Assistant 

to the President and Chief of Staff, 

entitled ‘‘Regulatory Freeze Pending 

Review,’’ instructed federal agencies to 

consider delaying the effective date of 

rules published in the Federal Register, 

but which have not yet taken effect, for 

a period of 60 days so that the new 

Administration may review recently 

published rules for ‘‘any questions of 

fact, law, and policy the rule may raise.’’ 

The memorandum notes certain 

exceptions that do not apply here. On 

January 20, 2021, the Office of 

Management and Budget (OMB) also 

published OMB Memorandum M–21– 

14, Implementation of Memorandum 

Concerning Regulatory Freeze Pending 

Review, which provides guidance 

regarding the Regulatory Freeze 

Memorandum. See OMB M–21–14, 

Implementation of Memorandum 

Concerning Regulatory Freeze Pending 

Review, https://www.whitehouse.gov/ 

wp-content/uploads/2021/01/M-21-14- 

Regulatory-Review.pdf. OMB M–21–14 

explains that pursuant to the Regulatory 

Freeze Memorandum, agencies ‘‘should 

consider postponing the effective dates 

for 60 days and reopening the 

rulemaking process’’ for ‘‘rules that have 

not yet taken effect and about which 

questions involving law, fact, or policy 

have been raised.’’ Id. In accordance 

with the Regulatory Freeze 

Memorandum and OMB M–21–14, HHS 

proposes to delay the effective date of 

the final rule revising the Vaccine Injury 

Table to April 23, 2021, which would be 

60 days beyond its original effective 

date. HHS needs to extend the effective 

date of the underlying rule by 60 days 

to determine whether its promulgation 

raises any legal issues, including but not 

limited to (1) whether the Advisory 

Commission on Childhood Vaccines 

was properly notified of the proposed 

rule pursuant to 42 U.S.C. 300aa–14(c), 

and (2) whether the public was properly 

notified of the entire revised regulation, 

42 CFR 100.3(b)–(e) (including the 

qualifications and aids to interpretation 

and the coverage provisions), given that 

both the proposed and final rules 

published in the Federal Register 

included only the revised Vaccine 

Injury Table itself, but not the entire 

revised regulation. HHS believes that 

the proposed delay is reasonable, would 

allow HHS time to receive public 

comments, and would not be disruptive 

since the underlying rule has not yet 

taken effect and the agency has not yet 

implemented the rule. 

HHS seeks comment on the proposed 

delay, including the proposed delay’s 

impact on any legal, factual, or policy 

issues raised by the underlying rule and 

whether further review of those issues 

warrants such a delay. All other 

comments on the underlying rule will 

be considered to be outside the scope of 

this rulemaking. HHS therefore seeks 

comment by February 16, 2021 on its 

proposal to extend the effective date by 

60 days to April 23, 2021. 

Norris Cochran, 

Acting Secretary, Department of Health and 

Human Services. 

[FR Doc. 2021–03069 Filed 2–11–21; 8:45 am] 

BILLING CODE 4165–15–P 

FEDERAL COMMUNICATIONS 

COMMISSION 

47 CFR Part 54 

[WC Docket No. 21–31; DA 21–98; FRS 

17466] 

Wireline Competition Bureau Seeks 

Comment on Petitions for Emergency 

Relief To Allow the Use of E-Rate 

Funds To Support Remote Learning 

During the COVID–19 Pandemic 

AGENCY: Federal Communications 

Commission. 

ACTION: Solicitation of comments. 

SUMMARY: In this document, the 

Wireline Competition Bureau (the 

Bureau) seeks comment on petitions for 

emergency relief from parties asking the 

Federal Communications Commission 

(Commission) to permit the use of ERate program funds to support remote 

learning during this unprecedented 

public health emergency. 

DATES: Comments are due February 16, 

2021 and Reply Comments are due 

February 23, 2021. 

ADDRESSES: Pursuant to sections 1.415 

and 1.419 of the Commission’s rules, 47 

CFR 1.415, 1.419, interested parties may 

file comments on or before February 16, 

2021, and reply comments on or before 

February 23, 2021. All filings should 

refer to WC Docket No. 21–31. 

Comments may be filed by paper or by 

using the Commission’s Electronic 

Comment Filing System (ECFS). See 

Electronic Filing of Documents in 

Rulemaking Proceedings, 63 FR 24121 

(1998). 

D Electronic Filers: Comments and 

replies may be filed electronically using 

the internet by accessing ECFS: http:// 

www.fcc.gov/ecfs. 

D Paper Filers: Parties who choose to 

file by paper must file an original and 

one copy of each filing. If more than one 

docket or rulemaking number appears in 

the caption of this proceeding, filers 

must submit two additional copies for 

each additional docket or rulemaking 

number. 

D Filings can be sent by commercial 

overnight courier or by first-class or 

overnight U.S. Postal Service mail. 

Filings must be addressed to the 

Commission’s Secretary, Office of the 

Secretary, Federal Communications 

Commission. 

D Commercial overnight mail (other 

than U.S. Postal Service Express Mail 

and Priority Mail) must be sent to 9050 

Junction Drive, Annapolis Junction, MD 

20701. 

D U.S. Postal Service first-class, 

Express, and Priority mail must be 

addressed to 45 L St NE, Washington, 

DC 20554. 

Effective March 19, 2020, and until 

further notice, the Commission no 

longer accepts any hand or messenger 

delivered filings. This is a temporary 

measure taken to help protect the health 

and safety of individuals, and to 

mitigate the transmission of COVID–19. 

FOR FURTHER INFORMATION CONTACT: 

Gabriela Gross, Wireline Competition 

Bureau, (202) 418–7400 or by email at 

Gabriela.Gross@fcc.gov. We ask that 

requests for accommodations be made 

as soon as possible in order to allow the 

agency to satisfy such requests 

whenever possible. Send an email to 

fcc504@fcc.gov or call the Consumer